Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 888 — Orthopedic Devices · § 888.3630

§ 888.3630. Resorbable shoulder spacer.

268 words·~1 min read·/us/cfr/t21/s§ 888.3630·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Identification. A resorbable shoulder spacer is intended to act as a temporary spacer, creating a physical barrier between tissues in the shoulder, for the treatment of massive irreparable rotator cuff tears.
(b)Classification. Class II (special controls). The special controls for this device are:
(1)Clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use and include the following:
(i)Evaluation of improvement of shoulder function and reduction of symptoms (e.g., pain and function) for the indications for use; and
(ii)Evaluation of relevant adverse events.
(2)Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use and include the following:
(i)Integrity testing of the device, including mechanical and chemical stability; and
(ii)Characterization of the device degradation profile.
(3)Animal performance testing must include evaluation of the following:
(i)Adverse effects, including gross necropsy and histopathology; and
(ii)Device degradation to verify in vitro versus in vivo degradation correlation.
(4)All patient-contacting components of the device must be demonstrated to be biocompatible.
(5)Performance data must support the sterility and pyrogenicity of the device components intended to be sterile.
(6)Performance data must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the identified shelf life.
(7)Labeling must include the following:
(i)Instruction for use, including specific instructions regarding device selection and placement;
(ii)A detailed summary of the clinical performance testing with the device, including procedure- and device-related complications or adverse events; and
(iii)A shelf life. [87 FR 981, Jan. 6, 2023]
Connections1 cite this
Citation graph
cites case law
§ 888.3630
Resorbable shoulder spacer.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.